Last Updated on January 8, 2024 by The Health Master
Prices of Remdesivir injection have been voluntarily curtailed by various drug companies on the intervention of the government, National Pharmaceutical Pricing Authority (NPPA) said on Saturday.
Drug companies like Cadila Healthcare, Dr Reddy’s Laboratories and Cipla have cut the prices of their respective brands of Remdesivir injection (100 mg/vial). The antiviral drug is used in the treatment of C-19.
To read rate list of 7 companies, click below link
NPPA-Office-memorandum-dt-17-04-2021-List-of-Reduced-Prices-of-Remdesivir-of-7-companies
“Due to the government’s intervention, the price of Remdesivir Injection is now reduced! I am thankful to pharmaceutical companies for joining hands with the Government to fight against C-19 Pandemic,” Union Minister of State for Chemicals and Fertilisers Mansukh L. Mandaviya tweeted.
To read more articles on Remdesivir, click here
See the prices below:
| S. No. | Name of the Company | Brand Name | Earlier MRP (Rs.) | Revised MRP (Rs.) |
| 1. | Cadila Healthcare Ltd | REMDAC | 2,800/- | 899/- |
| 2. | Syngene International Ltd (Biocon Biologics India) | RemWin | 3,950/- | 2,450/- |
| 3. | Dr. Reddy’s Laboratories Ltd | REDYX | 5,400/- | 2,700/- |
| 4. | CiplaLtd | CIPREMI | 4,000/- | 3,000/- |
| 5. | Mylan Pharmaceuticals Pvt Ltd | DESREM | 4,800/- | 3,400/- |
| 6. | Jubilant Generics Ltd | JUBI-R | 4,700/- | 3,400/- |
| 7. | Hetero Healthcare Ltd | COVIFOR | 5,400/- | 3,490/- |
According to the details shared by the NPPA, Cadila Healthcare has reduced the price of its REMDAC (Remdesivir 100 mg) injection to Rs 899 from Rs 2,800 earlier. Similarly, Syngene International has cut the price of its brand RemWin to Rs 2,450 from Rs 3,950 earlier.
To read more articles on NPPA, click here
Hyderabad-based Dr Reddy’s Laboratories has cut the price of REDYX, which used to cost Rs 5,400 earlier to Rs 2,700 now. Similarly, Cipla has reducedP of its CIPREMI brand to Rs 3,000 from Rs 4,000 earlier.
Mylan has also reduced the price of its brand from Rs 4,800 to Rs 3,400. Similarly, Jubilant Generics has cut the price of its remdesivir brand to Rs 3,400 from Rs 4,700 earlier.
Hetero Healthcare has also cut the price of its brand COVIFOR from Rs 5,400 to Rs 3,490 now.
Also read:
NPPA directs reduction in Remdesivir price
Nodal officer to check on supply of drugs
Australia good potential market for Indian generic medicines: Pharmexcil
Nasal spray for C-19 could be game changer for India: Scientist
Safe Medical Devices: 1,257 reports evaluated through reporting tools at IPC
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
